SPO Medical now listed on OTCBB

SPO Medical (New York), a developer of biosensor and microprocessor technologies for use in portable monitoring devices, reported that the company's shares are now quoted on the NASDAQ-operated Over-The-Counter Bulletin Board (OTCBB). The shares will continue to be quoted under ticker symbol SPOM.

Michael Braunold, president/CEO of SPO Medical, said, “We are delighted to report our transition to the OTCBB. Our listing on the OTCBB improves our market visibility, opens the door to a greater number of potential institutional investors and is a timely development. We have set out to accomplish a number of objectives for 2007 and listing on the OTCBB was one of them. We believe that the transition to the OTCBB will help improve SPO coverage in the capital markets to further shareholder value.”

Novadaq, Akorn on track with ICG supply

Novadaq Technologies (Toronto) said that it has received a sufficient supply of indocyanine green (ICG) to immediately resume normal business operations. Akorn (Buffalo Grove, Illinois), currently the exclusive suppliers of ICG in the U.S., said that they had have received a long-awaited approval for their alternate ICG manufacturing site from the FDA. The approval resolves all issues related to the short supply of ICG, which has adversely affected all users of ICG since March of 2007.

“As expected, the time it took to secure the new supply of ICG did break some of our momentum. Some of our customers chose to wait to place orders until the new ICG was introduced,” said Arun Menawat, president/CEO of Novadaq.

“However, now that we have resumed our normal operations our sales team is executing on the pipeline of new potential installs and I am pleased with their progress.”

Novadaq makes medical imaging systems and real-time image-guided therapies for use in the operating room.